Peer-reviewedCC BYCureus
De-escalating Therapy in Obstructive Sleep Apnoea After Glucagon-Like Peptide-1 Receptor Agonist-Induced Weight Loss: A Narrative Review
- 1Respiratory Medicine, University Hospitals of Leicester NHS Trust, Leicester, GBR
Related
- Initiation of Glucagon-Like Peptide-1 Receptor Agonist Therapy and Lifestyle Modifications for Morbid Obesity in a Patient With Paroxysmal Atrial Fibrillation, Severe Osteoarthritis, and Obstructive Sleep Apnea: A Case Report
- Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
- GLP-1, GIP, and Glucagon Receptor Agonism at the Obesity–Neurodegeneration Interface: A Narrative Review
- Chimeric Antigen Receptor T-cell (CAR-T) Therapy in Autoimmune Diseases: A Narrative Review
- Glucagon-Like Peptide-1 Receptor Agonist and Gastrointestinal Adverse Effects: A Comprehensive Review Efectos adversos gastrointestinales del agonista del receptor de GLP-1: revisión narrativa
BibTeX
@article{jalil2026deescalating,
title = {{De-escalating Therapy in Obstructive Sleep Apnoea After Glucagon-Like Peptide-1 Receptor Agonist-Induced Weight Loss: A Narrative Review}},
author = {Wares Jalil},
journal = {Cureus},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13676024},
note = {CC BY},
}
RIS
TY - JOUR
TI - De-escalating Therapy in Obstructive Sleep Apnoea After Glucagon-Like Peptide-1 Receptor Agonist-Induced Weight Loss: A Narrative Review
AU - Wares Jalil
PY - 2026
DA - 2026/10/19
JO - Cureus
UR - https://europepmc.org/article/PMC/PMC13676024
SN - 2168-8184
ER -